Australia · Delayed Price · Currency is AUD Resonance Health Company Description
Resonance Health Limited, a healthcare technology and services company, designs, develops, manufactures, and commercializes software-as-medical devices (SaMD) in the Asia Pacific, North America, Europe, the Middle East, and Africa.
It operates through SaMD, Resonance Clinical, and TrialsWest segments. The company offers FerriScan, a non-invasive MRI based solution for quantifying liver iron concentration (LIC); FerriSmart, an artificial intelligence (AI) solution for the automated real-time assessment of LIC; HepaFatScan, a non-invasive MRI-based solution for the assessment of liver-fat in liver tissue; HepaFatSmart, an AI-trained device for the automated real-time multi-metric measurement of liver-fat; LiverSmart, a non-invasive MRI-based multi-parametric device combining FerriSmart and HepaFatSmart into a consolidated report; and CardiacT2, a dual analysis service with FerriScan for assessing heart iron loading.
It also provides phantoms comprising FerriScan, R2*/T2*, T1CMR, and T2CMR phantoms for the calibration of MRI machines.
In addition, the company operates as an imaging contract research organization that provides comprehensive proposal and project management support, site set-up, imaging charter development, clinical reports, data transfer agreements, and compliance services for clinical trial sponsors.
It serves clinicians for the management of human diseases; and pharmaceutical and therapeutic companies for clinical trials.
Resonance Health Limited was incorporated in 1987 and is headquartered in Burswood, Australia.
| Country | Australia |
| Founded | 1987 |
| Industry | Health Information Services |
| Sector | Healthcare |
| Employees | 16 |
| CEO | Andrew Harrison |
Contact Details
Address: 141 Burswood Road Burswood, Washington 6100 Australia | |
| Phone | 61 8 9286 5300 |
| Website | resonancehealth.com |
Stock Details
| Ticker Symbol | RHT |
| Exchange | Australian Securities Exchange |
| Fiscal Year | July - June |
| Reporting Currency | AUD |
| ISIN Number | AU000000RHT2 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Andrew Duncan Harrison BCom (Hons), MAICD | Chief Executive Officer and Director |
| Benjamin Carruthers | Chief Financial Officer |
| Mitchell M. Wells B.Com., B.Comm, L.L.B. | Company Secretary and Non Executive Director |
| Gavin Pinto | Chief Technology Officer |
| Narelle Mounsey | General Manager of People and Culture |
| Dr. Wenjie Pang Ph.D. | Chief Scientific Officer ? Imaging and AI |
| Dr. Sherif Boulos Ph.D. | Chief Scientific Officer of Molecular |